Country: United States
Language: English
Source: NLM (National Library of Medicine)
SODIUM IODIDE I-123 (UNII: 29UKX3A616) (IODIDE ION I-123 - UNII:98QPV8670C)
Cardinal Health 418, Inc
SODIUM IODIDE I-123
IODIDE ION I-123 100 uCi
ORAL
PRESCRIPTION DRUG
Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. To date there are no known contraindications to the use of Sodium Iodide I 123 capsules.
Sodium Iodide I 123 is supplied as capsules for oral administration in strengths of 3.7 MBq (100 µCi) and 7.4 MBq (200 µCi) at time of calibration. Each gelatin capsule contains 0.45 - 0.65 g of sucrose. The capsules are packaged in plastic vials containing either one or five capsules of a single strength per vial. The plastic vial is packaged in a lead shield with a label identical to that affixed to the plastic vial. A package insert is supplied with each lead shield. The -I (Iodine) content for a 100 µCi capsule is 5.2 ng and the -I content for a 200 µCi capsule is 10.4 ng at TOC. Dispense and preserve capsules in well-closed containers that are adequately shielded. Store at room temperature, below 86°F. The contents of the capsules are radioactive. Adequate shielding and handling precautions must be maintained. THIS PACKAGE INSERT ISSUED APRIL 2018 Cardinal Health Denver, CO 80011 (303) 343-6800 Sodium Iodide I 123 1-020-16
New Drug Application
SODIUM IODIDE I 123- SODIUM IODIDE I 123 CAPSULE, GELATIN COATED CARDINAL HEALTH 418, INC ---------- SODIUM IODIDE I 123 DIAGNOSTIC-CAPSULES FOR ORAL ADMINISTRATION DESCRIPTION Sodium Iodide I 123 (Na I) for diagnostic use is supplied in capsules for oral administration. The capsules are available in strengths of 3.7 and 7.4 megabecquerels (MBq) (100 and 200 μCi) I 123 at time of calibration. Each capsule contains 0.3 µg - 3 µg Sodium Thiosulfate as a stabilizer. The radionuclidic composition at calibration is not less than 97.0 percent I 123, not more than 2.9 percent I 125 and not more than 0.1 percent all others (I 121 or Te 121.) The radionuclidic composition at expiration time is not less than 87.2 percent I 123, not more than 12.4 percent I 125 and not more than 0.4 percent all others. The ratio of the concentration of I 123 and I 125 changes with time. Graph 1 shows the maximum concentration of each as a function of time. GRAPH 1 RADIONUCLIDIC CONCENTRATION OF I 123 AND I 125 PHYSICAL CHARACTERISTICS Sodium Iodide I 123 decays by electron capture with a physical half-life of 13.2 hours. The photon that is useful for detection and imaging studies is listed in Table 1. TABLE 1 PRINCIPAL RADIATION EMISSION DATA Kocher, David C., Radioactive Decay Data Tables, DOE/TIC-11026, 122, (1981) RADIATION MEAN %/DISINTEGRATION MEAN ENERGY (KEV) Gamma-2 83.4 159 123 1 1 EXTERNAL RADIATION The specific gamma ray constant for I 123 is 1.6 R/hr-mCi at 1 cm. The first half value thickness of lead (Pb) for I 123 is 0.005 cm. A range of values for the relative attenuation of the radiation emitted by this radionuclide that results from the interposition of various thicknesses of Pb is shown in Table 2. For example, the use of 1.63 cm of lead will decrease the external radiation exposure by a factor of about 1,000. TABLE 2 RADIATION ATTENUATION BY LEAD SHIELDING Shleien, Bernard, The Health Physics and Radiological Health Handbook, Table 6.1.2, 169, (1992) SHIELD THICKNESS (PB), CM COEFFICIENT OF ATTENUATION 0.036 0.5 0.120 Read the complete document